BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9531173)

  • 41. Hemodialysis in a satellite unit: clinical performance target attainment and health-related quality of life.
    Diamant MJ; Young A; Gallo K; Xi W; Suri RS; Garg AX; Moist LM
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1692-9. PubMed ID: 21566106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality improvement activity directed at the national level: examples from the Health Care Financing Administration.
    Frankenfield DL; Marciniak TA; Drass JA; Jencks S
    Qual Manag Health Care; 1997; 5(4):12-8. PubMed ID: 10169781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A data-driven approach to improving the care of in-center hemodialysis patients.
    McClellan WM; Frederick PR; Helgerson SD; Hayes RP; Ballard DJ; McMullan M
    Health Care Financ Rev; 1995; 16(4):129-40. PubMed ID: 10151884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs.
    Hirth RA; Held PJ; Orzol SM; Dor A
    Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of quality guidelines implementation using a continuous quality improvement programme.
    Richards N; Ayala JA; Cesare S; Chazot C; Di Benedetto A; Gassia JP; Merello JI; Rentero R; Scatizzi L; Marcelli D
    Blood Purif; 2007; 25(3):221-8. PubMed ID: 17377376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of hemodialysis patients: modeling differences in risk of dialysis centers.
    Sá Carvalho M; Henderson R; Shimakura S; Sousa IP
    Int J Qual Health Care; 2003 Jun; 15(3):189-96. PubMed ID: 12803346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. XI. Annual facility survey of providers of ESRD therapy.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S140-3. PubMed ID: 10431010
    [No Abstract]   [Full Text] [Related]  

  • 49. Developing dialysis facility-specific performance measures for public reporting.
    Frederick PR; Maxey NL; Clauser SB; Sugarman JR
    Health Care Financ Rev; 2002; 23(4):37-50. PubMed ID: 12500469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.
    Patzer RE; Plantinga L; Krisher J; Pastan SO
    Am J Transplant; 2014 Jul; 14(7):1562-72. PubMed ID: 24891272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose of hemodialysis and survival: differences by race and sex.
    Owen WF; Chertow GM; Lazarus JM; Lowrie EG
    JAMA; 1998 Nov; 280(20):1764-8. PubMed ID: 9842952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UK Renal Registry 16th annual report: chapter 9 adequacy of haemodialysis in UK adult patients in 2012: national and centre-specific analyses.
    Shaw C; Steenkamp R; Davenport A
    Nephron Clin Pract; 2013; 125(1-4):171-81. PubMed ID: 24662173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variable mortality rates among dialysis treatment centers.
    McClellan WM; Flanders WD; Gutman RA
    Ann Intern Med; 1992 Aug; 117(4):332-6. PubMed ID: 1637029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient care staffing levels and facility characteristics in U.S. hemodialysis facilities.
    Yoder LA; Xin W; Norris KC; Yan G
    Am J Kidney Dis; 2013 Dec; 62(6):1130-40. PubMed ID: 23810689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between prevalent care process measures and facility-specific mortality rates.
    Lowrie EG; Teng M; Lacson E; Lew N; Lazarus JM; Owen WF
    Kidney Int; 2001 Nov; 60(5):1917-29. PubMed ID: 11703611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.
    Griffiths RI; Powe NR; Gaskin DJ; Anderson GF; de Lissovoy GV; Whelton PK
    Health Serv Res; 1994 Oct; 29(4):473-87. PubMed ID: 7928373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between dialysis performance measures: adequacy and anemia management.
    Spolter YS; Seliger SL; Zhan M; Hsu VD; Walker LD; Fink JC
    Am J Kidney Dis; 2007 Nov; 50(5):774-81. PubMed ID: 17954290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying the role of factors that limit attainment of K/DOQI urea reduction ratio dialytic goal.
    Press MH; Benz RL
    Clin Nephrol; 2006 Aug; 66(2):98-102. PubMed ID: 16939065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early winners and losers in dialysis center pay-for-performance.
    Saunders MR; Lee H; Chin MH
    BMC Health Serv Res; 2017 Dec; 17(1):816. PubMed ID: 29216894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.